Researchers are exploring the potential of a low-dose lithium supplement, available for as little as 10 pence, to protect against dementia and improve memory. While not widely recommended by medical professionals, emerging studies suggest a link between slightly elevated lithium levels in drinking water and reduced rates of dementia.
Although the human brain is born with a finite number of neurons, it retains the capacity to form new connections, known as synapses, throughout life. The ongoing research focuses on how lithium, even in trace amounts, might influence these synaptic processes and offer neuroprotective benefits.
Dr. Thomas MacLaren, a consultant psychiatrist at the Chelsea and Westminster Hospital in London, noted that several studies have indicated a correlation between slightly higher levels of lithium in public water supplies and lower instances of dementia. This observation has spurred further scientific interest into lithium's potential therapeutic applications for cognitive decline.
Supporting this line of inquiry, a clinical trial is underway at Johns Hopkins University in the United States. This trial is assessing the safety and tolerability of low-dose lithium orotate in adults diagnosed with early-stage Alzheimer's disease. The findings from such trials are anticipated to provide more definitive insights into lithium's role in managing neurodegenerative conditions.
The supplement in question, lithium orotate, is a form of lithium that is thought to be more readily absorbed by the body than other forms. While prescription-strength lithium is used to treat bipolar disorder, the doses investigated for cognitive benefits are significantly lower and available over-the-counter. The low cost of this supplement makes it an accessible option for potential preventative health strategies, pending further research validation.